The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on November 2, 2026

Nov. 2, 2026

New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation

Indeterminate GlobeNewswire

Nov. 2, 2026

Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China

Indeterminate GlobeNewswire

Nov. 2, 2026

AMLM Signs Earn-In Agreement to Earn Up to 85% Interest in Yuinmery Gold Project, Positioning Company for Significant Exploration Growth

Indeterminate GlobeNewswire

Nov. 2, 2026

UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

Nov. 2, 2026

Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets

Indeterminate GlobeNewswire

Nov. 2, 2026

Terra Balcanica Spin Off Terra North Resources Identifies Additional Uranium Targets over Fontaine lake, Saskatchewan

Indeterminate GlobeNewswire

Nov. 2, 2026

Lyell Immunopharma To Participate in November Investor Events

Indeterminate GlobeNewswire

Nov. 2, 2026

Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response

Indeterminate GlobeNewswire

Nov. 2, 2026

Crescent Biopharma to Present at November Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Dynacor Feeds First Ore to Ecuador Mill

Indeterminate GlobeNewswire

Nov. 2, 2026

Dynacor débute l’introduction de minerai à son usine en Équateur

Indeterminate GlobeNewswire

Nov. 2, 2026

Trekor to Release Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 2, 2026

Avicanna to Report Q3 2026 Results and Host Call on Nov. 12

Indeterminate GlobeNewswire

Nov. 2, 2026

CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position

Indeterminate GlobeNewswire

Nov. 2, 2026

Favikon Sitúa al Dr. Carmelo Santillán Ramos entre los Líderes Globales de Sustainability B2B en 2026

Indeterminate EIN Presswire

Nov. 2, 2026

Fredonia Confirms Continuity of Gold/Silver Mineralization and the Potential Expansion of the Conceptual EDM Mine Plan at Herradura Hill

Indeterminate GlobeNewswire

Nov. 2, 2026

Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Notes, as well as Concurrent Private Placement

Indeterminate GlobeNewswire

Nov. 2, 2026

Major Drilling Acquires Bunbury Drilling Company, Expanding into Specialized Mine Dewatering in Australia

Indeterminate GlobeNewswire

Nov. 2, 2026

Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November

Indeterminate GlobeNewswire